Patent Status

Patent Status(2016.03~2018.02)

Number registration date division Name of Patent
1 2016.02.19 domestic Composition for suppressing hepatitis B virus comprising p22-FLIP
2 2016.04.26 domestic A COMPOSITION FOR PREVENTING AND TREATING HEPATITIS B COMPRISING HEPATOCYSTIN
3 2016.05.04 domestic A METHOD FOR IMPROVING REPROGRAMMING POTENTIAL USE OF OVER EXPRESSION SOX2 GENE
4 2016.06.10 domestic METHOD FOR CULTURING SPERMATOGONIAL STEM CELLS WITHOUT FEEDER CELLS
5 2016.06.28 domestic SURFACE PROTEIN PRE S PEPTIDES OF HBV AND THEIR USE AS ANTI-HBV
6 2016.07.08 domestic COMPOSITION AND METHOD FOR PROMOTING DIRECT CONVERSION OF FIBROBLASTS INTO HEPATOCYTES
7 2016.07.18 domestic The Use of Thiazolidinediones for inhibiting p35 and p25 activity
8 2016.09.28 domestic METHOD FOR IMPROVING HYBRID STEM CELL AND PLURIPOTENT STEM CELL SURVIVAL
9 2016.10.07 domestic ANGPTL3 EXPRESSION INHIBITOR COMPRISING METHYLSULPHONYLMETHANE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING KETOSIS COMPRISING THE SAME AS AN ACTIVE INGREDIENT
10 2016.10.11 domestic A composition for treating neurological diseases and protecting nerve cell comprising resveratrol and taurine as effective component
11 2016.11.07 domestic Composition comprising neoagarooligosaccharide for preventing or treating sepsis or septic shock
12 2016.11.22 domestic DIAGNOSIS OF LIVER DISEASES AND SCREENING METHOD FOR DRUG CANDIDATES USING ALTERED EXPRESSION OF PHOSPHOLIPID AND ENZYME
13 2016.12.09 domestic Potential role of Brd2 as regulation target of Cerebral Nervous System
14 2017.01.11 domestic MATRIGEL COATING PLATE FOR NEURAL STEM CELL CULTURE
15 2017.02.03 domestic A METHOD FOR MEASURING REPROGRAMMING POTENTIAL USE OF CELL FUSION PROTOCOL
16 2017.03.29 domestic Treatment for the degenerative brain diseases mediated by Tau proteins
17 2017.03.30 domestic A METHOD FOR PREDICTING REPLICATION AND DIAGNOSING MULTI-DRUG RESISTANT HEPATITIS B VIRUS
18 2017.05.02 domestic Method for inducing reprogramming to liver cell used for single specific transmission factor of liver cell and small molecules
19 2017.05.25 domestic Method for forming mesenchymal stem cell aggregation
20 2017.05.29 domestic Method for enhancing direct reprogramming efficiency from somatic cells to hepatocyte-like cells using small molecules
21 2017.06.30 domestic Pharmaceutical Composition for Preventing or Treating Cognitive Dysfunction or Concentration Disorder Comprising Eclalbasaponin or its derivatives
22 2017.08.09 domestic METHOD OF DIRECT CONVERSION OF FIBROBLASTS INTO HEPATOCYTES USING NON-VIRAL VECTORS
23 2017.08.22 domestic Method for Screening a Composition for Preventing or Treating cancer using BRD4-E2F2 cell cycle regulation
24 2017.08.31 domestic ANIMAL AS MODELS FOR WOUND, METHOD OF MANUFACTURING THEREOF AND METHOD OF ANALYZING EFFICACY OF WOUND THERAPEUTIC AGENT USING THEREOF
25 2017.09.05 domestic Pharmaceutical composition comprising TRAIL and autophagy inhibitor as an active ingredient for prevention or treatment of hepatitis virus B infection
26 2017.09.28 domestic Composition comprising ADK and antibiotics for preventing or treating sepsis or septic shock
1 2017.09.12 Overseas METHOD FOR MEASURING CELL-TO-CELL TRANSMISSION OF ALPHA-SYNUCLEIN AGGREGATES USING BIMOLECULAR FLUORESCENCE

  • Most of the patents mentioned above are related with the purpose of the project team, which is related to the mediation technology that can be linked to practical use. In the period of 2016.03 ~ 2018.02, 35 technology transfer of the technology is carried out based on the patents of the project team